Atazanavir and Lamivudine for Treatment Simplification
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Objectives of the study:
1. To verify the safety of the study treatment, defined as the persistent control of the
virus' replication at 48 weeks after the simplification to lamivudine + atazanavir with
ritonavir.
2. To collect relevant information about the safety and the metabolic impact of this
strategy in order to eventually design a non-inferiority randomized controlled trial for
the evaluation of the safety and the efficacy of this strategy in the future.